Journal of Biomedical Science · 2014 · 107 citations · 34 references
MedicineOncologyPharmacologyCarcinogenesisMetastasisSignal TransductionBiomarkers Of Liver InjuryHepatic NecrosisHepatic PathophysiologyLiver MetastasisColorectal Liver MetastasisCurative TherapyLiver Metastases TreatmentMetastatic Liver TumorsTumor Necrosis Factor Inhibitor TherapyTumor Necrosis Factor Therapy
BACKGROUND: Patients with colorectal cancer (CRC) often develop liver metastases, in which case surgery is considered the only potentially curative treatment option. However, liver surgery is associated with a risk of ischemia-reperfusion (IR) injury, which is thought to promote the growth of colorectal liver metastases. The influence of IR-induced tumor necrosis factor alpha (TNF-α) elevation in the process still is unknown. To investigate the role of TNF-α in the growth of pre-existing micrometastases in the liver following IR, we used a mouse model of colorectal liver metastases. In this model, mice received IR treatment seven days after intrasplenic injections of colorectal CT26 cells. Prior to IR treatment, either TNF-α blocker Enbrel or low-dose TNF-α, which could inhibit IR-induced TNF-α elevation, was administered by intraperitoneal injection. RESULTS: Hepatic IR treatment significantly promoted CT26 tumor growth in the liver, but either Enbrel or low-dose TNF-α pretreatment reversed this trend. Further studies showed that the CT26 + IR group prominently increased the levels of ALT and AST, liver necrosis, inflammatory infiltration and the expressions of hepatic IL-6, MMP9 and E-selectin compared to those of CT26 group. Inhibition of TNF-α elevation remarkably attenuated the increases of these liver inflammatory damage indicators and tumor-promoting factors. CONCLUSION: These findings suggested that inhibition of TNF-α elevation delayed the IR-enhanced outgrowth of colorectal liver metastases by reducing IR-induced inflammatory damage and the formation of tumor-promoting microenvironments. Both Enbrel and low-dose TNF-α represented the potential therapeutic approaches for the protection of colorectal liver metastatic patients against IR injury-induced growth of liver micrometastases foci.
34
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay, Hai‐Rim Shin, Freddie Bray et al. · International Journal of Cancer · 2010 · 21.4K citations
Lloyd J. Old · Science · 1985 · 1.9K citations
Life Sciences, Immunology, Oncology +12
Lisa M. Colletti, Daniel G. Remick, GORDON D. BURTCH et al. · Journal of Clinical Investigation · 1990 · 820 citations · Full text
Oncogenic Ras Diverts a Host TNF Tumor Suppressor Activity into Tumor Promoter
Julia B. Cordero, Juan Pablo Macagno, Rhoda Stefanatos et al. · Developmental Cell · 2010 · 238 citations · Full text
Medicine, Cancer Biology, Oncology +16